Background and Format: Launched in 2003, Medical News Today is a website overseen by Healthline Media UK Ltd and is aimed at healthcare professionals and consumers. Covers health news, diseases, nutrition & diet and pain & aesthetics. For more information about advertising rates, the team can be reached here. Circulation: Source: Publisher.

ASH Clinical News is a news publication from the American Society of Hematology and serves as a source for worldwide news and perspectives on hematology and oncology. Coverage includes blood disorders and related topics of interest to hematologists, including developments in oncology, endocrinology and cardiology. Each month it provides the latest updates in the field along with perspectives and opinions from key leaders as well as tools and resources to help clinicians with quality and performance improvement, patient education, and the economics of running a practice.

Edited for practicing hematologists, oncologists and hem/onc specialists with an emphasis on diagnosis, treatment and pharmacology. Content offers news on clinical developments in the field and includes a practice management section covering malpractice, legislative changes and socioeconomic issues. Covers clinical news in hematology and oncology. Contains the most up-to-date news in both oncology and hematology, including topics in non-malignant blood disorders, such as lupus, anemia and clotting disorders. While the emphasis is on diagnosis, treatment and pharmacology, the practice management section presents information on malpractice, legislative and socioeconomic topics of interest to hematologists and oncologists. Features news articles, commentary, news notes, letters to the editor, product news, meetings and courses, practice management, Washington update, legal affairs, News You Can Eat, final consult, virtual digest, point and counter point, pharmacology consult, What's Your Diagnosis and special reports.

Impact factor: 4.411 (Thomson Reuters, 2016) Journal Ranking: 48/213  (Oncology) (Thomson Reuters, 2016) Affiliations: Blood Cancer Journal is a sister journal to Leukemia. Aims of the journal: Blood Cancer Journal is a peer-reviewed, online, open access, sister journal to Leukemia. The journal aims to bring the fore outstanding pre-clinical and clinical research in the field of hematology, with ramifications into translational biology research down to new therapies. Contents: Topics of particular concentration will include, but are not limited to, the following: Careful analysis of validation of in-vitro experimentations of new compounds devoted to phase 1 studies Murine models Therapies such as specific inhibitory molecules, antibodies, immunotherapy manipulations Editorial contacts: Any correspondence, queries or additional requests for information on the Manuscript Submission process should be sent to the editorial office at bcj@nature.com Manuscript Submission: Instructions for Authors can be found here. Online submission at http://mts-bcj.nature.com/cgi-bin/main.plex

Impact factor: 3.213 (2015) Five-Year Impact Factor: 2.684 Journal Ranking: 26 out of 70 (Hematology) and 93 out of 187 (Cell Biology). (Thomson Reuters, Journal Citation Reports 2016 for 2015 ranks) Circulation: A figure is not disclosed. Frequency: It has 8 issues per year. Aims of the journal: Platelets is an international, fully peer-reviewed journal covering all aspects of platelet-related research. It provides the opportunity for contributors and readers from all scientific several disciplines to engage with progress on platelet function, biochemistry, signal transduction, pharmacology and therapeutics, interaction with other cells in the blood vessel wall and the contribution of platelets and platelet-derived products to health and disease. Content: It publishes original articles, review articles and correspondence on blood platelets and platelet-related areas with a view to providing a focus for new information on all aspects of this blood component. In addition to the usual reviews and research articles, there is a Methods section, a unique feature. With the growing complexity and enormous range of different methodologies involved in research on platelets that, coupled with increasing utility of new technologies, benefits researchers worldwide. Manuscript submission: Information for authors can be found here. Online submission can be found here.